Clinical Trial Update: Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial registry entry evaluating cannabidiol (CBD) for regulating meal-time anxiety in individuals with Anorexia Nervosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of California, San Diego | Conditions: Anorexia Nervosa | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING